AR224499A1 - Procedimiento para preparar esteres de derivados de aril-1 amino-2-alcoholes - Google Patents

Procedimiento para preparar esteres de derivados de aril-1 amino-2-alcoholes

Info

Publication number
AR224499A1
AR224499A1 AR272020A AR27202078A AR224499A1 AR 224499 A1 AR224499 A1 AR 224499A1 AR 272020 A AR272020 A AR 272020A AR 27202078 A AR27202078 A AR 27202078A AR 224499 A1 AR224499 A1 AR 224499A1
Authority
AR
Argentina
Prior art keywords
aril
amino
procedure
alcohol derivatives
preparing esters
Prior art date
Application number
AR272020A
Other languages
English (en)
Spanish (es)
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU77236A external-priority patent/LU77236A1/xx
Priority claimed from LU77237A external-priority patent/LU77237A1/xx
Application filed by Continental Pharma filed Critical Continental Pharma
Application granted granted Critical
Publication of AR224499A1 publication Critical patent/AR224499A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AR272020A 1977-05-03 1978-05-03 Procedimiento para preparar esteres de derivados de aril-1 amino-2-alcoholes AR224499A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU77236A LU77236A1 (sv) 1977-05-03 1977-05-03
LU77237A LU77237A1 (sv) 1977-05-03 1977-05-03

Publications (1)

Publication Number Publication Date
AR224499A1 true AR224499A1 (es) 1981-12-15

Family

ID=26640226

Family Applications (1)

Application Number Title Priority Date Filing Date
AR272020A AR224499A1 (es) 1977-05-03 1978-05-03 Procedimiento para preparar esteres de derivados de aril-1 amino-2-alcoholes

Country Status (21)

Country Link
US (1) US4474977A (sv)
JP (1) JPS5940140B2 (sv)
AR (1) AR224499A1 (sv)
AT (1) AT358020B (sv)
CA (1) CA1118438A (sv)
CH (1) CH635570A5 (sv)
DE (1) DE2817494A1 (sv)
DK (1) DK189878A (sv)
ES (1) ES469843A1 (sv)
FI (1) FI781347A (sv)
FR (1) FR2389597B1 (sv)
GR (1) GR64990B (sv)
IE (1) IE47194B1 (sv)
IL (1) IL54608A (sv)
IT (1) IT1113140B (sv)
MX (1) MX5160E (sv)
NL (1) NL7804621A (sv)
NO (1) NO146057C (sv)
PT (1) PT67969B (sv)
SE (1) SE7804897L (sv)
YU (1) YU106178A (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
CA2415678A1 (en) * 2000-07-13 2003-01-10 Sankyo Company Limited Amino alcohol derivatives
US6399828B1 (en) * 2001-10-29 2002-06-04 Boehringer Ingelheim Chemicals, Inc. Preparation of amphetamines from phenylpropanolamines
EP1546105A1 (en) * 2002-07-17 2005-06-29 Lek Pharmaceutical and Chemical Co. D.D. Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them
CA2585645C (en) * 2004-10-29 2014-10-21 Musc Foundation For Research Development Ceramides and apoptosis-signaling ligand
GB0624757D0 (en) * 2006-12-12 2007-01-17 Sosei R & D Ltd Novel compounds
JP5721631B2 (ja) 2008-11-06 2015-05-20 ムスク ファウンデーション フォー リサーチ デベロップメント 酸性セラミダーゼのリソソーム親和性阻害剤
CN101759665B (zh) * 2008-12-23 2012-03-28 江苏恩华药业股份有限公司 取代苯基哌嗪芳烷醇衍生物及其在制备镇痛药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1799110A (en) * 1928-07-21 1931-03-31 Lilly Co Eli Process of producing ephedrine and structurally-similar compounds and products of such process
NL112967C (sv) 1961-05-09
NL298924A (sv) * 1962-10-18
AT244932B (de) 1963-06-04 1966-02-10 Haessle Ab Verfahren zur Herstellung von neuen Phenyläthanolaminen und ihren Salzen
GB1043510A (en) * 1963-10-09 1966-09-21 Bayer Ag D-(--)-n-alkyl-1-phenyl-2-aminoethanols
DE1593837A1 (de) 1967-06-29 1970-10-29 Degussa Verfahren zur Herstellung von neuen Aminoketonen
US3714229A (en) * 1969-07-10 1973-01-30 Merck & Co Inc ESTERS OF 3-HYDROXY- alpha -(1-AMINOETHYL)-BENZYL ALCOHOL
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
US4018825A (en) * 1972-07-27 1977-04-19 Warner-Lambert Company 5-Hydroxy-α-(substituted aminomethyl)-m-xylene-α,α'-diols
US3809714A (en) * 1972-08-31 1974-05-07 Interx Research Corp Novel ester of ((methylamino)methyl) benzyl alcohol
GB1390748A (en) * 1973-04-09 1975-04-16 Continental Pharma Alkyl and cycloalkylthiophenylalkylaminoalkanols their salts and the preparation thereof
US4009179A (en) * 1975-10-15 1977-02-22 E. I. Du Pont De Nemours And Company Di- and tri-substituted oxazolidin-2-one oximes

Also Published As

Publication number Publication date
IL54608A0 (en) 1978-07-31
SE7804897L (sv) 1978-11-04
NO146057C (no) 1982-07-21
GR64990B (en) 1980-06-11
IT1113140B (it) 1986-01-20
FI781347A (fi) 1978-11-04
IL54608A (en) 1984-01-31
IE780867L (en) 1978-11-03
PT67969B (fr) 1979-11-14
MX5160E (es) 1983-04-11
CH635570A5 (fr) 1983-04-15
DK189878A (da) 1978-11-04
IT7822985A0 (it) 1978-05-03
NO781554L (no) 1978-11-06
JPS53141230A (en) 1978-12-08
CA1118438A (en) 1982-02-16
FR2389597A1 (sv) 1978-12-01
NO146057B (no) 1982-04-13
YU106178A (en) 1983-01-21
ES469843A1 (es) 1979-09-16
IE47194B1 (en) 1984-01-11
AT358020B (de) 1980-08-11
DE2817494A1 (de) 1978-11-09
FR2389597B1 (sv) 1983-08-19
NL7804621A (nl) 1978-11-07
PT67969A (fr) 1978-05-01
JPS5940140B2 (ja) 1984-09-28
ATA317978A (de) 1980-01-15
US4474977A (en) 1984-10-02

Similar Documents

Publication Publication Date Title
MX5950E (es) Procedimiento para la preparacion de derivados de la pirrolidin-2-ona
MX5527E (es) Procedimiento para la preparacion de derivados de carboestirilo
AR230270A1 (es) Procedimiento para preparar nuevos derivados de 2-alquiltio-3(-alcanoil alcoxicarbonil)-5-halogeno-6-fenoxi-bencimidazol substituidos
AR230184A1 (es) Procedimiento para preparar derivados de 1-benzil-imidazol
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
MX4988E (es) Procedimiento para la preparacion de derivados pirrolidinicos
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
MX5479E (es) Procedimiento para la preparacion de derivados de 1-oxadetiacefalosporinas
MX151851A (es) Procedimiento mejorado para preparar derivados de triacina
MX5215E (es) Procedimiento de preparacion de derivados de tienopiridina
MX6291E (es) Procedimiento para preparar derivados de n-bencilhalogenoacetamida
AR224499A1 (es) Procedimiento para preparar esteres de derivados de aril-1 amino-2-alcoholes
AR218296A1 (es) Procedimiento para la preparacion de nuevos derivados de 14-beta-amino-morfina
AR226119A1 (es) Procedimiento para preparar derivados de 4-sulfamoilfenil-3-sustituido-2-fenil-imino-4-tiazolina
AR219926A1 (es) Procedimiento para preparar esteres de acidos 1-oxido-7-acilamido-3-exometilen-ceam-4-carboxilicos
MX4884E (es) Procedimiento para la preparacion de derivados de la tienopiridina
MX5368E (es) Procedimiento para la preparacion de esteres de acidos ciclopropancarboxilicos
MX5905E (es) Procedimiento para la preparacion de esteres de acidos ciclopropancarboxilicos
MX5398E (es) Procedimiento para preparar esteres de alfa-ciano-bencilo
AR218311A1 (es) Procedimiento para la preparacion de derivados de fenoximetil-2-imidazolina
SE7802694L (sv) Forfarande for framstellning av isobutyramidderivat
RO78489A (ro) Procedeu pentru prepararea tiadiazolil-benzamidelor
MX5515E (es) Procedimiento para preparar ester tetra-nicotinico de papaverolina
MX5292E (es) Procedimiento para la preparacion de derivados de piridilo
MX5103E (es) Procedimiento para preparar derivados de pirimidina